CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 105  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0522
LYS 10.0222
GLU 20.0033
LEU 30.0180
ARG 40.0236
CYS 50.0214
GLN 60.0266
CYS 70.0230
ILE 80.0217
LYS 90.0109
THR 100.0164
TYR 110.0167
SER 120.0110
LYS 130.0318
PRO 140.0136
PHE 150.0222
HIS 160.0115
PRO 170.0215
LYS 180.0378
PHE 190.0361
ILE 200.0078
LYS 210.0102
GLU 220.0221
LEU 230.0262
ARG 240.0285
VAL 250.0165
ILE 260.0138
GLU 270.0222
SER 280.0090
GLY 290.0292
PRO 300.0130
HIS 310.0204
CYS 320.0149
ALA 330.0165
ASN 340.0145
THR 350.0177
GLU 360.0051
ILE 370.0063
ILE 380.0182
VAL 390.0073
LYS 400.0104
LEU 410.0105
SER 420.0128
ASP 430.0232
GLY 440.0216
ARG 450.0191
GLU 460.0171
LEU 470.0042
CYS 480.0119
LEU 490.0054
ASP 500.0138
PRO 510.0164
LYS 520.0272
GLU 530.0103
ASN 540.0063
TRP 550.0078
VAL 560.0102
GLN 570.0150
ARG 580.0091
VAL 590.0132
VAL 600.0131
GLU 610.0208
LYS 620.0055
PHE 630.0109
LEU 640.0162
LYS 650.0276
ARG 660.0087
ALA 670.0287
GLU 680.0229
ASN 690.0522

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.